Coastal Investment Advisors, Inc. Abbott Laboratories Transaction History

Coastal Investment Advisors, Inc.

$504 Million
Q2 2024

A detailed history of Coastal Investment Advisors, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Coastal Investment Advisors, Inc. holds 3,212 shares of ABT stock, worth $361,028. This represents 0.07% of its overall portfolio holdings.

Number of Shares

3,212

Previous 3,358 4.35%

Holding current value

$361,028

Previous $381,000 12.6%

% of portfolio

0.07%

Previous 0.08%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$100.73 - $112.44 $14,706 - $16,416	-146 Reduced 4.35%	3,212 $333,000
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $61,112 - $67,495	-558 Reduced 14.25%	3,358 $381,000
Q4 2023 Jan 19, 2024	SELL	$90.19 - $110.4 $46,538 - $56,966	-516 Reduced 11.64%	3,916 $431,000
Q3 2023 Oct 20, 2023	SELL	$95.53 - $114.62 $67,444 - $80,921	-706 Reduced 13.74%	4,432 $429,000
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $58,351 - $65,015	579 Added 12.7%	5,138 $560,000
Q1 2023 May 05, 2023	SELL	$96.86 - $114.01 $165,436 - $194,729	-1,708 Reduced 27.25%	4,559 $461,000
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $61,408 - $72,041	-646 Reduced 9.34%	6,267 $688,000
Q3 2022 Oct 27, 2022	SELL	$96.76 - $112.03 $21,674 - $25,094	-224 Reduced 3.14%	6,913 $669,000
Q2 2022 Aug 09, 2022	SELL	$102.07 - $123.37 $8,982 - $10,856	-88 Reduced 1.22%	7,137 $787,000
Q1 2022 Apr 13, 2022	SELL	$114.02 - $139.04 $122,343 - $149,189	-1,073 Reduced 12.93%	7,225 $855,000
Q4 2021 Jan 18, 2022	SELL	$115.53 - $141.46 $8,087 - $9,902	-70 Reduced 0.84%	8,298 $1.17 Million
Q3 2021 Oct 18, 2021	BUY	$116.66 - $129.06 $5,016 - $5,549	43 Added 0.52%	8,368 $989,000
Q2 2021 Jul 15, 2021	BUY	$105.79 - $124.53 $133,612 - $157,281	1,263 Added 17.88%	8,325 $965,000
Q1 2021 Apr 12, 2021	SELL	$108.84 - $128.23 $37,223 - $43,854	-342 Reduced 4.62%	7,062 $846,000
Q4 2020 Jan 13, 2021	BUY	$105.0 - $114.42 $173,985 - $189,593	1,657 Added 28.83%	7,404 $811,000
Q3 2020 Oct 23, 2020	BUY	$91.64 - $111.29 $6,781 - $8,235	74 Added 1.3%	5,747 $625,000
Q2 2020 Jul 16, 2020	BUY	$76.57 - $98.0 $2,909 - $3,724	38 Added 0.67%	5,673 $519,000
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $61,689 - $90,206	-982 Reduced 14.84%	5,635 $445,000
Q4 2019 Feb 05, 2020	BUY	$78.51 - $87.4 $51,581 - $57,421	657 Added 11.02%	6,617 $570,000
Q3 2019 Oct 18, 2019	SELL	$81.84 - $88.74 $6,874 - $7,454	-84 Reduced 1.39%	5,960 $494,000
Q2 2019 Aug 01, 2019	BUY	$72.88 - $85.0 $64,134 - $74,800	880 Added 17.04%	6,044 $505,000
Q1 2019 May 15, 2019	BUY	$66.22 - $80.06 $341,960 - $413,429	5,164 New	5,164 $413,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastal Investment Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Coastal Investment Advisors, Inc. with notifications on news.

Account

Coastal Investment Advisors, Inc. Abbott Laboratories Transaction History